News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Poukalov Konstantin
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/05/2023 |
4
| Poukalov Konstantin (Director) has filed a Form 4 on Lyra Therapeutics, Inc.|
Txns:
| Granted 20,000 options
@ $4.11, valued at
$82.2k
|
|
| 06/27/2022 |
4
| Poukalov Konstantin (Director) has filed a Form 4 on LianBio|
Txns:
| Granted 36,300 options to buy
@ $2.52, valued at
$91.5k
|
|
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2021 |
4
| Poukalov Konstantin (10% Owner) has filed a Form 4 on Landos Biopharma, Inc.|
Txns:
| Bought 27,453 shares
@ $11.14, valued at
$305.8k
Bought 34,611 shares
@ $11.38, valued at
$393.9k
Bought 86,671 shares
@ $12.53, valued at
$1.1M
Bought 1,771 shares
@ $13.1, valued at
$23.2k
Bought 64,730 shares
@ $13.8, valued at
$893.3k
Bought 34,951 shares
@ $14.6, valued at
$510.3k
|
|
| 02/08/2021 |
4
| Poukalov Konstantin (10% Owner) has filed a Form 4 on Landos Biopharma, Inc.|
Txns:
| Converted 13,369,728 shares
@ $0
Bought 1,250,000 shares
@ $16, valued at
$20M
Converted 5,883,538 preferred shares
@ $0
Converted 7,486,190 preferred shares
@ $0 |
|
| 05/01/2020 |
4
| Poukalov Konstantin (Director) has filed a Form 4 on Lyra Therapeutics, Inc.|
Txns:
| Granted 14,500 options
@ $16, valued at
$232k
|
|
| 12/12/2017 |
4
| Poukalov Konstantin (Executive Vice President, CFO) has filed a Form 4 on Kadmon Holdings, Inc.|
Txns:
| Granted 205,000 rights
@ $3.64, valued at
$746.2k
|
|
| 12/16/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/14/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|